These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257 [TBL] [Abstract][Full Text] [Related]
3. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Pollack AE; Thomas LI Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912 [TBL] [Abstract][Full Text] [Related]
4. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
5. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats. Pinna A; Di Chiara G Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944 [TBL] [Abstract][Full Text] [Related]
6. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates. Byrnes EM; Bruno JP Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729 [TBL] [Abstract][Full Text] [Related]
7. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349 [TBL] [Abstract][Full Text] [Related]
8. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats. Pollack AE; Yates TM Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212 [TBL] [Abstract][Full Text] [Related]
9. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. Wang JQ; McGinty JF J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408 [TBL] [Abstract][Full Text] [Related]
10. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat. Simson PE; Johnson KB; Jurevics HA; Criswell HE; Napier TC; Duncan GE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Dec; 263(3):1454-63. PubMed ID: 1361576 [TBL] [Abstract][Full Text] [Related]
11. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain. Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342 [TBL] [Abstract][Full Text] [Related]
12. D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja. Wirtshafter D Synapse; 1998 Feb; 28(2):154-9. PubMed ID: 9450515 [TBL] [Abstract][Full Text] [Related]
13. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. McPherson RJ; Marshall JF Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899 [TBL] [Abstract][Full Text] [Related]
14. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Paul ML; Graybiel AM; David JC; Robertson HA J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113 [TBL] [Abstract][Full Text] [Related]
15. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Paul ML; Currie RW; Robertson HA Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877 [TBL] [Abstract][Full Text] [Related]
16. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574 [TBL] [Abstract][Full Text] [Related]
17. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Campbell BM; Kreipke CW; Walker PD Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829 [TBL] [Abstract][Full Text] [Related]
18. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists. Cauli O; Morelli M Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482 [TBL] [Abstract][Full Text] [Related]
19. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS; Joyce JN Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220 [TBL] [Abstract][Full Text] [Related]
20. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Berridge KC; Aldridge JW Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]